Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication

Scientific Reports
Mi-Kyung ParkJinjong Myoung

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is causally associated with several malignant tumors: Kaposi's sarcoma (KS), multicentric Castleman's disease (MCD), and primary effusion lymphoma (PEL). KS remains the most common AIDS-related malignancy since the AIDS epidemic and thus has been extensively studied. KS is characterized as an angioproliferative disease with massive immune cell infiltration at the early stage. High levels of proinflammatory cytokines and growth factors are found in KS lesions, and their involvement in the survival and growth of tumor cells has been well characterized. However, little is known about the role of the inflammatory microenvironment in the regulation of KSHV gene expression and/or viral replication. In the present study, we demonstrated that IFN-γ and TNF-α profoundly inhibited KSHV progeny production in primary human lymphatic endothelial cells (LECs) as well as induced KSHV-producer cells (iSLK.219) with doxycycline. Of note, IFN-γ inhibited overall KSHV gene expression, while the effects of TNF-α were confined to a selected set of genes, which were also downregulated by IFN-γ. The addition of IFN-γ up to 36 hr after induction of viral lytic replication was effective in terms of the inh...Continue Reading

References

Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S A MilesT Kishimoto
Jun 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A OxholmK Bendtzen
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·N DupinC Boshoff
Jun 15, 2000·The American Journal of Pathology·M MercaderK E Foreman
Nov 9, 2000·The New England Journal of Medicine·J PaukL Corey
Feb 24, 2001·Cancer Treatment and Research·B Herndier, D Ganem
Jun 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B EnsoliP Monini
Jun 30, 2001·Advances in Cancer Research·B EnsoliP Monini
Apr 22, 2003·Seminars in Hematology·Jeffrey N Martin
Jul 15, 2003·Journal of Virology·Helen J BrownRen Sun
Apr 7, 2004·The Journal of Experimental Medicine·Ilaria GuasparriEthel Cesarman
Sep 28, 2004·The Journal of General Virology·Veronika P PozharskayaMargaret K Offermann
Dec 15, 2005·Journal of Virology·Ashley L SteedHerbert W Virgin
Apr 7, 2010·The Journal of Clinical Investigation·Don Ganem
Sep 19, 2012·International Journal of Cancer. Journal International Du Cancer·Michael StürzlRamona Jochmann
Sep 25, 2014·MBio·Mina C HosseinipourDirk P Dittmer
Nov 7, 2014·Viruses·Veenu Minhas, Charles Wood
Nov 15, 2014·International Journal of Cancer. Journal International Du Cancer·Katie WakehamRobert Newton

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR
flow cytometry

Software Mentioned

GenePix Pro
FlowJo
Java
ImageJ
Treeview

Related Concepts

Related Feeds

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.